The relationship between left ventricular geometric remodeling and cardiac function in essential hypertension

Shigeya Oda1, Minoru Yoshiyama, Naoya Ichiba

  • 1Asakayama General Hospital, Japan.

Osaka City Medical Journal
|April 12, 2005
PubMed

Insights

Diastolic dysfunction is common in hypertensive heart disease, regardless of left ventricular (LV) geometry. However, the severity of diastolic impairment varies across different LV geometric patterns in these patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • Abnormal left ventricular (LV) diastolic relaxation is an early indicator of hypertensive heart disease.
  • The relationship between diastolic dysfunction and LV geometric patterns in hypertension is not fully understood.

Purpose of the Study:

  • To investigate the association between left ventricular (LV) diastolic function and various LV geometric patterns in hypertensive patients.
  • To determine if diastolic dysfunction severity differs based on LV geometry.

Main Methods:

  • Echocardiography was used to evaluate 220 hypertensive patients.
  • Four LV geometric patterns were identified: normal geometry, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy.
  • Diastolic function was assessed using E/A ratio, E wave deceleration time (Dct), and isovolumic relaxation time (IRT).

Main Results:

  • All patient groups exhibited prolonged E/A ratio and Dct, indicating diastolic dysfunction.
  • Isovolumic relaxation time (IRT) was significantly longer in patients with concentric and eccentric hypertrophy compared to normal geometry and concentric remodeling groups (p < 0.05).

Conclusions:

  • Diastolic dysfunction can occur in hypertensive patients irrespective of their left ventricular (LV) geometric pattern.
  • The degree of diastolic function impairment is influenced by the specific LV geometric pattern present in hypertensive individuals.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...